LncRNA GAS5 Regulates Gemcitabine Resistance in Pancreatic Carcinoma by Targeting miRNA-21

K Huang, G Yang - Annals of Clinical & Laboratory Science, 2023 - Assoc Clin Scientists
Objective Gemcitabine is the first-line drug for chemotherapy of pancreatic cancer. However,
owing to the inherent and acquired resistance, gemcitabine does not change obviously the …
被引用次数：4 相关文章

LncRNA GAS5 Regulates Gemcitabine Resistance in Pancreatic Carcinoma by Targeting miRNA-21.

K Huang, G Yang - Annals of Clinical and Laboratory Science, 2023 - europepmc.org
Objective Gemcitabine is the first-line drug for chemotherapy of pancreatic cancer. However,
owing to the inherent and acquired resistance, gemcitabine does not change obviously the …

LncRNA GAS5 Regulates Gemcitabine Resistance in Pancreatic Carcinoma by Targeting miRNA-21

K Huang, G Yang - Annals of clinical and laboratory …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Gemcitabine is the first-line drug for chemotherapy of pancreatic cancer. However,
owing to the inherent and acquired resistance, gemcitabine does not change obviously the …